Home » CMS Expands Coverage for Ventricular Assist Devices
CMS Expands Coverage for Ventricular Assist Devices
The Centers for Medicare & Medicaid Services (CMS) has decided to cover ventricular assist device implantation as a destination therapy for some patients with end-stage ventricular heart failure. To qualify, patients must not be a candidate for heart transplant, have failed to respond to optimal medical management for 40 of the last 60 days, have a left ventricular injection fraction greater than 25 percent and have demonstrated functional limitation with a peak oxygen of ≤ 14 ml/kg/min. The decision is explained in a memo released this week.
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May